OpenAI's New Revenue Chief Tightens Enterprise Sales

OpenAI has introduced GPT-Red, an automated red teaming system that uses self-play to identify and address vulnerabilities in AI models. The system is designed to improve safety, alignment, and robustness against prompt injection attacks. GPT-Red represents an approach to proactive AI security testing that could inform how organizations evaluate model vulnerabilities before deployment.

OpenAI has released Codex Micro, a limited-run hardware device developed with keyboard maker Work Louder. The square button pad is designed to help users monitor and manage AI agents within OpenAI's Codex coding platform. This marks OpenAI's first hardware release, separate from its ongoing collaboration with designer Jony Ive on a consumer AI device currently facing legal challenges.

OpenAI has outlined a 'reverse federalism' approach to AI governance in which state-level laws work together to establish a national framework for safe and democratic AI development. The approach positions state action as foundational to building coherent federal policy rather than the traditional top-down model. This represents a shift in how the AI industry and policymakers are thinking about regulatory coordination across jurisdictions.

OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup that has attracted funding discussions valuing the company at $2 billion. The funding interest reflects growing investor appetite for applying AI to life sciences and pharmaceutical development. The startup has not yet been formally launched, but the valuation signals confidence in AI's potential to accelerate drug discovery processes.